Lenacapavir Approved for HIV Prevention
This is a news story, published by CBS News, that relates primarily to Gilead Sciences' news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCBS News news
For more news from CBS News, you can click here:
more news from CBS NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
HIV funding. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest HIV vaccine design news, new HIV infections news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
HIV vaccine researchCBS News
•Health
Health
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

83% Informative
Gilead Sciences' drug called Yeztugo is approved as a twice-yearly injection to prevent HIV.
99.9% of participants in clinical trials who received it remained HIV negative.
The drug's approval meets an existing need, but the Trump administration's funding decisions have rolled back progress for a vaccine.
VR Score
87
Informative language
88
Neutral language
67
Article tone
formal
Language
English
Language complexity
49
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links